Skip to content

Psoriasis and compression therapy

Psoriasis and compression therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00016626
Enrollment
30
Registered
2019-01-28
Start date
2019-04-04
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L40 R60

Interventions

Group 1: Randomized single-sided analysis (one leg: therapy with standard of care and compression therapy, the other leg: only standard of care therapy) Therapy with standard of care and compression

Sponsors

Universitätsklinikum Essen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Age = 18 - Psoriasis vulgaris for at least 6 months - edema on both lower legs - Psoriatic plaques on both lower legs - Patient must be able to put compression stockings on and off by her- or himself.

Exclusion criteria

Exclusion criteria: - Inadequate ability to communicate in the German language or lack of comprehension of the German language or dementia or (functional) illiteracy - Lack of or unwillingness to sign the informed consent form - Decompensated heart failure - Advanced polyneuropathy - Pregnancy and breast feeding period - Critical ischemia, KADI (ankle-brachial pressure index) 40

Design outcomes

Primary

MeasureTime frame
The clinical response of psoriatic plaques at the lower legs comparing both sides (standard of care vs. standard of care and compression) as measured by PASI (Psoriasis Area and Severity Index) and BSA (Body Surface Area) and LSS (Lesion Severity Score) after four weeks.

Secondary

MeasureTime frame
The health-related quality of life, overall and in relation to the research question (DLQI (Dermatology Life Quality Index) measurement) - The development of any pain on the lower legs (VAS (Visual Analogue Scale)) - The development of leg circumference / lower leg edema (circumferential measurement by defined measuring points) - The satisfaction / experience with the compression therapy from the patient's point of view (as assessed by questionnaire) All endpoints will be assessed after 4 weeks.

Countries

Germany

Contacts

Public ContactWiebke Sondermann

Universitätsklinikum Essen (AöR), Klinik für Dermatologie, Venerologie und Allergologie

wiebke.sondermann@uk-essen.de0201-723-3648

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026